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Cardiovascular and metabolic responses to submaximal exercise in he-
modialysis patients. Eight chronic hemodialysis (cHD) patients and six
healthy sedentary controls (C) were exercised for 60 minutes at 52
8% (cHD patients) and 48 4% (C) of their maximal oxygen consump-
tion levels. Plasma lactate levels at rest and during exercise were com-
parable in both groups. Respiratory exchange ratios were lower in cHD
patients, but they increased during exercise to levels comparable to
those of the C group. Despite comparable heart rates at rest, exercise
of similar intensity led to lower heart rates at 30 and 60 minutes in cHD
patients compared to C (P < 0.05). The cHD patients had higher sys-
tolic and mean arterial pressures at rest than did C (P < 0.05), but dur-
ing exercise the increments in systolic and mean blood pressures were
lower in cHD patients than they were in C (P < 0.05). In spite of these
blunted cardiovascular responses, plasma catecholamines increased
during exercise in both groups. Plasma glucose levels were similar in
both groups during exercise in spite of significantly higher plasma lev-
els of insulin and glucagon in cHD patients throughout the exercise ses-
sion (P < 0.01). These data demonstrate that chronic cHD patients can
exercise at a modest intensity for a prolonged period of time without
untoward cardiovascular or metabolic responses. Their poor exercise
response does not appear to be related to an inadequate activation of
the sympathoadrenal system.
Réponses cardlo-vasculaires et metabotiques a un exercice sub-maxi-
mal chez des malades hémodialysés. Huit hemodialyses chroniques
(cHD) et six contrôles sédentaires sains (C) ont subi un exercice pen-
dant 60 minutes a 52 8% (les malades cHD) et 48 4% (C) de leur
niveau de V02 max, respectivement. Les niveaux de lactate plasma-
tique au repos et durant l'exercice étaient comparables dans les deux
groupes. Les rapports d'échange respiratoire étaient plus faibles chez
les cHD, mais s'élevaient au cours de l'exercice a des niveaux com-
parables a ceux de C. Malgré des rythmes cardiaques comparables au
repos, un exercice d'intensité similaire conduisait a des pouls plus lents
a 30 et 60 mm chez les cHD que chez les C (P < 0,05). Les cHD avai-
ent des pressions artérielles systoliques et moyennes plus élevées au
repos que C (P < 0,05), mais pendant l'exercice, les élévations des pres-
sions artérielles systoliques et moyennes étaient moindres chez cHD
que chez C (P < 0,05). Malgré ces réponses cardio-vasculaires plus
faibles, les catécholamines plasmatiques s'élevaient pendant l'exercice
dans les deux groupes. Les niveaux de glycémie étaient identiques
dans les deux groupes pendant l'exercice malgré des niveaux d'insuline
et de glucagose plasmatiques plus élevés chez les cHD tout au long de
Ia séance d'exercice (P < 0,01). Ces données démontrent que les cHD
peuvent effectuer un exercice d'intensité modérée pendant une période
de temps prolongée sans réponses cardiovasculaires ou métaboliques
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inadaptées. La faible réponse a l'exercice des cHD ne parait pas reliée
a une activation inadequate du système sympathique.
Levels of physical fitness, as determined by the measure-
ment of maximal oxygen consumption (V02 max), are low in
uremic patients treated with chronic hemodialysis [1, 21. The
improved cardiovascular and metabolic function of some he-
modialysis patients after endurance exercise training suggests
that their sedentary lifestyle and low level of physical fitness
contribute to some of their medical complications [1, 2].
Endurance exercise training improves physical work capac-
ity, and it reduces heart rates at rest and during submaximal
exercise in normal individuals [31. These changes during pro-
longed exercise affect hormone and substrate responses to pro-
vocative stimuli such as intravenous glucose, the ingestion of
fat, and acute exercise at submaximal or maximal workloads
[3—8]. Exercise at submaximal workloads elicits significant
cardiovascular responses (increased heart rate and blood pres-
sure) and alters sympathoadrenal activity and glucose metabo-
lism [3, 6]. Plasma insulin usually decreases, and plasma
glucagon and catecholamine levels rise in normal subjects dur-
ing exercise at an intensity of 50 to 60% of V02 max for longer
than 30 minutes [4—6]. Glucose, free fatty acids and muscle gly-
cogen provide the energy for this exercise [9]; yet, in spite of
the increased glucose utilization by muscle, plasma glucose
levels usually remain constant or decrease slightly during the
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exercise [4, 5].
The relationship between lipolysis and catecholamine levels
is influenced by the plasma insulin concentration. When insu-
lin levels or tissue sensitivity are increased during exercise,
lipolysis may be inhibited and glucose uptake enhanced [11].
Conversely, peripheral tissue resistance to insulin, elevated
plasma free fatty acid levels and increased plasma concentra-
tions of hormones such as glucagon, catecholamines, growth
hormone and parathyroid hormone, which inhibit insulin's ac-
tion and stimulate lipolysis [6, 12, 131, reduce glucose uptake
by peripheral tissues during exercise [14]. Alternatively, an en-
hanced release of gluconeogenic precursors from exercising
muscle might stimulate a greater than normal compensatory in-
crease in hepatic glucose production and raise plasma glucose
levels during exercise [15, 161. These responses are influenced
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by the individual's health status and level of physical fitness,
as well as by the intensity and the duration of the exercise
[3—8]. If the intensity of the exercise session is fixed at the same
relative percentage of V02 max, then the cardiovascular and
metabolic responses to exercise can be compared among dif-
ferent subjects [3, 91.
The role of these factors in the regulation of glucose metabo-
lism in uremic patients, and the hormone and substrate re-
sponses during submaximal exercise are not known in uremic
patients. This study was designed to compare the responses of
the cardiovascular system and the changes in sympathoad-
renal activity and blood glucose regulation between hemodi-
alysis patients and normal subjects during low intensity
submaximal exercise.
Methods
Patients and controls. The patient group was composed of 8
patients (5 females and 3 males); mean age, 29.6 3.6 years;
age range, 21 to 53 years with endstage renal disease treated
by chronic hemodialysis (cHD). They had received dialysis 3
times per week, 4 hours per session, for at least 6 months prior
to the study. Residual renal function was less than 1 cc/mm.
All were anemic, with hematocrits ranging from 15 to 30%, all
had normal blood pressures requiring no antihypertensive
medications, and all were of normal weight (106 9% ideal
body wt). Three patients received treatment with digoxin.
None had diabetes mellitus, hepatitis, severe peripheral
neuropathy, claudication, or angina pectoris. Their routine
medications were aluminum hydroxide in variable doses, fer-
rous sulfate (900 mg/day), multivitamins, calcium carbonate,
and in men, norandrenalone decanoate (100 mg, i.m., every 2
weeks).
The control group was composed of 6 healthy sedentary
nonuremic controls (4 males, 2 females) of similar mean ages
(31 2 years; range, 25 to 41) and ideal body wts (106 3%).
They all had normal blood pressures and hematocrits, and did
not take any medications. The medical regimen, diets, and
weights of the patients and controls were stable at the time of
study. Informed consent was provided by all participants.
The patients and controls provided a full medical history and
underwent a thorough physical examination. A resting electro-
cardiogram (ECG) and a graded exercise treadmill test was ad-
ministered according to the protocol of Bruce and Hornsten
[17] as modified by Goldberg et al [1]. If there were no com-
plications or side effects, these individuals underwent another
treadmill test to determine their V02 max [18].
Prolonged submaximal exercise. All studies were performed
after a 12-hour overnight fast. The hemodialysis (HD) patients
were studied on an intermediate dialysis day, at least 24 hours
after their last treatment. Prior to exercise, a polyethylene
catheter was placed in the AV fistula of the HD patients and in
an antecubital vein of the controls. After 30 minutes of rest in
the supine position, heart rate and blood pressure were re-
corded, and a blood sample was drawn. The participants then
sat upright for 10 minutes before their blood pressure and heart
rates were recorded and another blood sample was drawn.
They then exercised on a bicycle ergometer at a work rate se-
lected to elicit approximately 50% of their V02 max for I
hour's duration. The bicycle ergometer was used because most
individuals, especially those with chronic diseases, cannot ex-
ercise at 50% of V02 max on a treadmill for this duration of
time. Three ECG leads were displayed continuously on an os-
cilloscope during the exercise. After 10, 30, and 60 minutes of
exercise, a blood sample was drawn, heart rate and blood pres-
sure were recorded, and expired gases were collected for de-
termination of V02 and the respiratory exchange ratio (ratio of
02 consumption to CO2 production). These same measure-
ments were made in the seated position 10 and 30 minutes af-
ter the completion of the exercise session. Blood samples were
analyzed for levels of norepinephrine, epinephrine, insulin,
glucagon, glucose, lactate, protein, hemoglobin, and hemato-
crit as described next.
Analytical methods. Blood samples (3 ml) were drawn into a
chilled tube containing reduced glutathione and pargyline in so-
dium heparin. The plasma was separated at 4° C and frozen al
— 70° C for measurement of plasma norepinephrine and epi-
nephrine levels by a single isotope derivative method with ap-
propriate internal standards [19, 201. Three additional blood
samples (1 ml) were collected in chilled tubes containing dried
traysolol and EDTA. The plasma was again separated at 4° C
and stored at —70° C for measurement of insulin and glucagon
levels [21, 22]. Plasma lactate levels were determined as pre-
viously described [4]. Plasma glucose levels were determined
by the glucose oxidase method (Beckman Autoanalyzer, Ful
lerton, CA). Protein was measured by the method of Lowry
[231, and hemoglobin and hematocrit were measured by stand-
ard autoanalyzer techniques.
Statistical methods. The Student's paired t test was used to
determine if the responses to exercise within a group were sig-
nificant [24]. The significance of differences between the he-
modialysis patients and the control subjects was determined
with Student's t test [24]. All data are expressed as the means
the standard error of the mean (sEM).
Results
Both groups had the expected heart rate, blood pressure, and
ECG responses during the graded exercise treadmill stress test.
The changes in pulse rate in the controls were linearly related
to changes in V02 (Table 1). At 50% of V02 max, the pulse
rates of the HD patients were approximately 20% less than
those observed in the control population. Table 1 contains pa-
tients included in this study as well as previous studies to il-
lustrate that HD patients achieve V02 max at a lower heart rate
reserve than do controls. No test was discontinued because of
an abnormal response; rather, in all instances fatigue was the
end point. The V02 max values of the RD patients were sig-
nificantly lower (23.4 2.5 ml 02/kg/min) than those of the
control subjects (41.4 3.1 ml 02/kg/min, P < 0.01). Hema-
tocrit levels (24 2% vs. 43 2%, P < 0.01) and hemoglobin
concentrations (7.8 0.5 vs. 15.1 0.5 g/dl; P < 0.01) also
were lower in the HD than the control group.
During the 1-hour exercise test, V02 increased to compa-
rable relative levels in both the HD patients (P < 0.01) and con-
trols (P < 0.01). These levels of V02 were at the same relative
work load (that is, the same percentage of V02 max) in both
groups (control, 48 4% of V02 max; HD patients, 52 8%
of V02 max; Fig. I). Plasma lactate levels after 30 and 60 min-
utes of exercise were the same in the HD patients (at 30 mm,
1.9 0.4; at 60 mm, 1,7 0.3 mM) as they were in the con-
trols (at 30 mm, 1.4 0.5, P = NS; at 60 mm, 1.3 0.1 mM,
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Fig. 2. Effects ofsubmaximal exercise on heart rate, systolic and di-
astolic blood pressure, and mean arterial pressure in normal controls
(O—O) and hemodialysis patients (•—•).
fat for energy (Fig. 1). During exercise, however, their respi-
ratory exchange ratios increased significantly (P < 0.05 vs. ba-
sal at 30 and 60 mm) to levels that were not different from those
in the control subjects (Fig. 1).
Hematocrits increased 8.3 2% in the cHD patients and 7.0
3% in the controls during the exercise session. Baseline se-
rum protein concentrations were comparable in both groups.
Minimal variation in these values occurred during the exercise
session (controls, 5.2 0.8%; cHD patients, 4.7 0.5%), in-
dicating that significant hemoconcentration probably did not
occur.
Both groups had similar heart rates at rest, but during ex-
ercise heart rates were lower in the cHD patients (P < 0.05 at
30 and 60 mm; Fig. 2) than the controls. The increments in
heart rate during exercise were significant in both groups (P <
0.01, each group), but the relative changes were greater in the
controls than in the cHD patients at each time point during ex-
ercise (P < 0.05, Fig. 2). The cHD patients had higher systolic
and mean arterial blood pressures at rest (P < 0,05, Fig. 2) than
the controls did, but the increments in both their systolic and
mean arterial blood pressures during the exercise session were
smaller than those in the controls (P < 0.05 at 30 and 60 mm
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Fig. 1. Time course of changes in oxygen consumption (V02) and res-
piratory exchange ratio in normal controls (0—0)and hemodialysis
patients (•—•) during submaximal exercise and recovery.
Table 1. Relationship between percent heart rate reserve and percent
V02 maxa
00
.-.10
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toP<0.05, +P<0.01 vs. controls
Diastolic
0
"P < 0.05 vs. controls
30 60 70 90
observed HR resting HRPercent heart rate (HR) reserve =
maximal HR — resting HR
P = NS), suggesting that the work intensities during the ex-
ercise session were comparable in both groups.
The respiratory exchange ratio was lower in the HD patients
both before and after exercise, indicating a greater reliance on
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for systolic blood pressure, and P < 0.05 for mean arterial
pressure at 30 mm vs. control, Fig. 2). The mean increase in
mean arterial blood pressure during exercise was significant in
the controls (at 30 mm, 15 5%, P < 0.05; at 60 mm, 13
4%, P < 0.05) but not in the cHD patients (at 30 mm, 8 6%;
at 60 mm, 4 4%; P = NS; Fig. 2).
The differences in the cardiovascular responses between
controls and cHD patients during exercise were not due to im-
paired sympathoadrenal responses in these patients. Despite
comparable baseline plasma levels of norepinephrine in both
groups, the increments in the plasma norepinephrine concen-
trations during exercise were higher in the cHD patients (0 to
30 mm, 104 36%; 0 to 60 mm, 132 43%) than in the con-
trols (0 to 30 mm, 58 24%; 0 to 60 mm, 84 20%; P <0.05;
Fig. 3). Absolute levels of epinephrine were higher in the cHD
patients than in the controls throughout the study in both the
supine position (54 9 vs. 22 4 pg/mI; P < 0.02), and the
sitting position (66 9 vs. 9 3 pg/mI; P < 0.05; Fig. 3),
probably reflecting arterialized samples used for analyses. The
changes in the epinephrine levels were greater in controls (113
27%) than in cHD patients (27 15%, P < 0.05) after 30
minutes of exercise but did not differ between the groups at 60
minutes (controls, 141 34%; vs. cHD patients, 92 46%; P
NS; Fig. 3). During recovery, plasma norepinephrine and
epinephrine levels returned to baseline in both groups within 30
minutes of cessation of exercise.
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Fig. 4. Changes in plasma glucose, insulin, and glucagon levels in nor-
mal controls (0—0) and hemodialysis patients (S—•) during
subrnaximal exercise and recovery.
Plasma glucose levels were similar in both groups in the ba-
sal state (Fig. 4). Fasting plasma insulin and glucagon levels
were higher in the cHD patients than in the controls, and re-
mained higher throughout the exercise and recovery periods
(Fig. 4). There was a slight reduction in plasma insulin levels
(P = NS) in both groups during exercise; plasma glucagon lev-
els rose slightly during exercise in the cHD group but did not
change in the controls (Fig. 4). In spite of the significant dif-
ferences in the absolute plasma insulin and glucagon levels of
the two groups throughout the study, plasma glucose levels re-
mained constant in both groups throughout the exercise ses-
sion (Fig. 4).
Discussion
This study demonstrates that although hemodialysis patients
are in poor physical condition, they are capable of working at
a submaximal workload approximating 50% of their maximal
oxygen consumption for one hour in the fasted state without
risk of sustaining significant abnormalities in cardiovascular he-
modynamics or glucose homeostasis. Because both the chronic
hemodialysis patients and the controls exercised at compa-
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rable relative work rates, the experimental design necessitated
that the absolute work rates of the controls be higher than
those for dialysis patients. The comparable plasma lactate con-
centrations of the controls and the dialysis patients after 30 and
60 minutes of exercise suggest that their relative intensities of
exercise were the same. Oxygen consumption during exercise
was significantly lower in the hemodialysis patients compared
to values in the controls. This was associated with a smaller
rise in heart rate, systolic blood pressure, and mean arterial
blood pressure during exercise in the hemodialysis patients
than in the controls despite greater increments in plasma nor-
epinephrine after 30 and 60 minutes in these patients. On the
other hand, plasma epinephrine levels, which were signifi-
cantly higher in the hemodialysis patients at rest, rose compa-
rable amounts in both groups by 60 minutes during exercise.
The data demonstrate that the supine norepinephrine levels
measured in arterialized (A-V fistula) plasma samples from
these normotensive hemodialysis patients were comparable to
levels measured in the controls. These data are in agreement
with those reported by several other investigators [25, 26].
Measurement of norepinephrine levels at the time of hemodi-
alysis is frequently associated with elevated plasma levels of
this hormone [27, 28], whereas resting supine levels have been
shown to be normal in several studies [25, 29]. Although pre-
vious studies have suggested that arteriovenous differences in
plasma norepinephrine are not different [301, more recent stud-
ies have documented that peripheral metabolism of catechola-
mines is dependent on the plasma level of these hormones
themselves [31]. Thus, it is not possible to directly relate the
arterialized samples obtained in the dialysis patients to the ve-
nous samples obtained in the control population. On the other
hand, data from Izzo et al [32], who used venous blood sam-
ples, have demonstrated an increased metabolic clearance rate,
half life and endogenous production rate of norepinephrine in
hemodialysis patients. Whether hyperactivity of the sympa-
thetic nervous system exists in hemodialysis patients during
submaximal exercise is not clear. Comparison of venous cat-
echolamine levels between the hemodialysis patients and the
controls would be required.
The plasma epinephrine levels of the hemodialysis patients
at baseline and throughout exercise were significantly higher
than values in the control subjects. These results probably re-
flect the arterialization of the blood sample, because epineph-
rine is predominantly produced from the adrenal medulla and
cleared in a variety of peripheral sites including the distal fore-
arm. This causes arterial epinephrine concentrations to be ap-
proximately twice the venous levels [31]. The percent changes
in epinephrine levels induced by the exercise session were,
however, similar in both groups, thereby suggesting that the
epinephrine responses were comparable in the hemodialysis
patients and the controls. Sympathoadrenal activity at least
partially determines the exercise-related increments in the
heart rate and blood pressure [33, 34] in normal individuals.
The finding of smaller increases in heart rates and blood pres-
sures in the dialysis patients cannot be due to decreased ac-
tivity of the sympathoadrenal system in these patients because
the hormonal responses were at least similar in both groups.
Whether resistance to the cardiovascular actions of cate-
cholamines exists in these patients will require further
investigation.
Plasma glucose concentrations remained constant in both the
hemodialysis patients and the controls during exercise even
though absolute plasma levels of insulin and glucagon at rest
and during exercise were significantly higher in the dialysis pa-
tients. The elevated plasma levels of insulin and glucagon in ur-
emia are, in part, due to the reduced renal clearance of both
the active and inactive circulating forms of these hormones [35,
36]. Consequently, the hypoglycemic effects of hyperinsulin-
emia and the hyperglycemic effects of hypergiucagonemia are
usually not manifest in uremia, nor would they correlate with
the plasma hormone levels unless the metabolically active moi-
eties are isolated and measured. In the present study, all par-
ticipants were studied after an overnight fast. The changes in
glucose and glucoregulatory hormones during exercise were
similar in both groups, except that plasma glucagon levels rose
slightly during the exercise session in the dialysis patients but
not in the controls. Further studies are underway to examine
the interaction among these hormones and their effects on glu-
cose and protein metabolism in the basal state, after acute ex-
ercise, and following prolonged exercise training. Whether sig-
nificant differences in sympathoadrenal responses and blood
glucose regulation will occur between hemodialysis patients
and normal subjects at higher relative workloads remains to be
determined.
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